ストックスクリーナーアプリを入手
0.2901
1.69%
-0.005
アフターアワーズ：
.27
-0.0201
-6.93%
前日終値:
$0.2951
開ける：
$0.3
24時間の取引高:
128.19K
Relative Volume:
0.35
時価総額：
$13.63M
収益：
$7.10M
当期純損益:
$-39.43M
株価収益率:
-0.3086
EPS:
-0.94
ネットキャッシュフロー:
$-46.50M
1週間 パフォーマンス:
-12.06%
1か月 パフォーマンス:
-25.42%
6か月 パフォーマンス:
-38.91%
1年 パフォーマンス:
-63.09%
1日の値動き範囲:
$0.2825
$0.30
1週間の範囲:
$0.2801
$0.3451
52週間の値動き範囲:
$0.2801
$0.87
Spruce Biosciences Inc Stock (SPRB) Company Profile
名前
Spruce Biosciences Inc
セクター
電話
(415) 655-4168
住所
611 GATEWAY BOULEVARD, SUITE 740, SOUTH SAN FRANCISCO
SPRB を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
SPRB
Spruce Biosciences Inc
|
0.2901 | 13.63M | 7.10M | -39.43M | -46.50M | -0.94 |
|
VRTX
Vertex Pharmaceuticals Inc
|
484.82 | 131.41B | 11.02B | -535.60M | -978.00M | -2.20 |
|
REGN
Regeneron Pharmaceuticals Inc
|
634.23 | 72.26B | 14.20B | 4.41B | 3.54B | 38.28 |
|
ARGX
Argen X Se Adr
|
591.87 | 36.10B | 2.19B | 833.04M | -1.28B | 12.71 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
270.02 | 35.03B | 2.25B | -278.16M | -42.59M | -2.17 |
|
ONC
Beigene Ltd Adr
|
272.17 | 28.24B | 3.81B | -644.79M | -669.77M | -6.24 |
Spruce Biosciences Inc Stock (SPRB) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2024-12-11 | ダウングレード | JMP Securities | Mkt Outperform → Mkt Perform |
| 2024-12-11 | ダウングレード | Oppenheimer | Outperform → Perform |
| 2024-03-14 | ダウングレード | Guggenheim | Buy → Neutral |
| 2024-03-14 | ダウングレード | H.C. Wainwright | Buy → Neutral |
| 2024-03-14 | ダウングレード | Ladenburg Thalmann | Buy → Neutral |
| 2024-03-14 | ダウングレード | Leerink Partners | Outperform → Market Perform |
| 2024-03-14 | ダウングレード | RBC Capital Mkts | Outperform → Sector Perform |
| 2024-02-21 | 開始されました | Guggenheim | Buy |
| 2021-12-17 | 開始されました | Oppenheimer | Outperform |
| 2021-12-10 | 開始されました | The Benchmark Company | Speculative Buy |
| 2021-11-16 | ダウングレード | SVB Leerink | Outperform → Mkt Perform |
| 2021-07-19 | 開始されました | H.C. Wainwright | Buy |
| 2021-04-26 | 再開されました | Credit Suisse | Outperform |
| 2020-11-03 | 開始されました | Cowen | Outperform |
| 2020-11-03 | 開始されました | Credit Suisse | Outperform |
| 2020-11-03 | 開始されました | RBC Capital Mkts | Outperform |
| 2020-11-03 | 開始されました | SVB Leerink | Outperform |
すべてを表示
Spruce Biosciences Inc (SPRB) 最新ニュース
Spruce Biosciences Delays Annual Report Filing - TipRanks
Layoff Tracker: Arbutus Cuts 57% of Workforce - BioSpace
12 Health Care Stocks Moving In Monday's Pre-Market Session - Benzinga
Spruce Biosciences stock hits 52-week low at $0.32 - Investing.com
In-Depth Analysis Of The Global Congenital Adrenal Hyperplasia Market: Key Drivers, Trends, Growth Opportun... - WhaTech
SPRUCE BIOSCIENCES INC- The GF Score's 5 Key Aspects of Analysis - GuruFocus.com
Invivyd, Inc. (IVVD) Reports Q4 Loss, Tops Revenue Estimates - Yahoo Finance
Analysts Set Spruce Biosciences, Inc. (NASDAQ:SPRB) PT at $2.38 - Defense World
SPRB Stock Touches 52-Week Low at $0.34 Amid Steep Decline - Investing.com India
Agenus (AGEN) Reports Q4 Loss, Lags Revenue Estimates - Yahoo Finance
Spruce Biosciences (SPRB) to Release Quarterly Earnings on Wednesday - Defense World
Harbour Biomed newco HBM Alpha pens $395M hyperplasia drug deal - BioWorld Online
SPRB stock touches 52-week low at $0.34 amid sharp annual decline - Investing.com
Short Interest in Kingsoft Co. Limited (OTCMKTS:KSFTF) Increases By 79.4% - Defense World
Archer-Daniels-Midland Company (NYSE:ADM) Receives Consensus Rating of “Reduce” from Brokerages - Defense World
Traws Pharma, Inc. (NASDAQ:TRAW) Short Interest Update - Defense World
Spruce Biosciences, Inc. (NASDAQ:SPRB) Short Interest Up 81.4% in February - Defense World
SPRB stock touches 52-week low at $0.34 amid sharp annual decline By Investing.com - Investing.com South Africa
Spruce Biosciences, Inc. (SPRB) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Seek Compensation for Alleged Wrongdoings - ACCESS Newswire
Spruce Biosciences, Inc. (SPRB) Reports Q2 Loss, Tops Revenue Estimates - MSN
NeoGenomics (NEO) Tops Q4 Earnings Estimates - Yahoo Finance
The Prothena Corporation plc (PRTA) had a good session last reading, didn’t it? - US Post News
Element Solutions Inc (NYSE:ESI) Receives $30.14 Consensus Price Target from Analysts - Defense World
Alamos Gold Inc. (TSE:AGI) Receives C$28.78 Average Target Price from Brokerages - Defense World
Spruce Biosciences, Inc. (NASDAQ:SPRB) Receives $3.90 Consensus Target Price from Analysts - Defense World
Spruce Biosciences Inc [SPRB] Investment Appeal on the Rise - Knox Daily
Spruce Biosciences Inc (NASDAQ: SPRB) Stock Has Gained 4.05% Over The Month – Is There Room For Growth? - Marketing Sentinel
Should You Expect Akero Therapeutics Inc (NASDAQ:AKRO) To Recover From Its 70.02% Gain From Highs? - Marketing Sentinel
Five Point Holdings LLC (NYSE: FPH): Can The Stock Still Lose Despite An 54.23% YTD Gain? - Marketing Sentinel
Why you might not want to use AI to spruce up your job application - Yahoo
Spruce Biosciences Inc (SPRB) Stock Price and Analyst Predictions - The News Heater
Spruce Biosciences Inc (NASDAQ:SPRB) stock: You might be surprised - US Post News
Examining OppFi Inc (OPFI) stock is warranted - US Post News
(PDF) Efficacy and safety of revefenacin for nebulization in patients with chronic obstructive pulmonary disease taking concomitant ICS/LABA or LABA: subgroup analysis from phase III trials - ResearchGate
Spruce Biosciences, Inc. (NASDAQ:SPRB) Receives $3.90 Consensus Target Price from Brokerages - Defense World
After A 1.47% Jump In The Last Week, Does Amprius Technologies Inc (NYSE: AMPX) Still Make Sense To Buy? - Marketing Sentinel
CMS’ price negotiations take two: Ozempic, Xtandi among 15 drugs chosen - BioWorld Online
Neurocrine Sues to Clear New Drug of Spruce's Patent 'Ransom' - Bloomberg Law
Spruce Biosciences Inc (SPRB) 財務データ
収益
当期純利益
現金流量
EPS
1.05%
1.79%
大文字化:
|
ボリューム (24 時間):